Description of the 3 Tranquillo Phase 3 clinical program study designs to assess ritlecitinib treatment in adults and adolescents with nonsegmental vitiligo. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s714. https://doi.org/10.25251/rm8etw25